FDA inspection
Valeant Pharmaceuticals International, Inc: FDA inspection ending Feb 14, 2012
FDA inspection 767400 · Voluntary Action Indicated (VAI) · Saint-Laurent
Key facts
| Inspection ID | 767400 |
|---|---|
| Firm | Valeant Pharmaceuticals International, Inc |
| FEI number | 3002807243 |
| Address | 1956 Bourdon St |
| City | Saint-Laurent |
| Country | Canada |
| Fiscal year | 2012 |
| Inspection end date | Feb 14, 2012 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data